-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Relay Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
- Relay Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $26.8M, a 14.6% increase year-over-year.
- Relay Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $95.1M, a 31.3% increase year-over-year.
- Relay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $86M, a 53.2% increase from 2022.
- Relay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $56.1M, a 15.9% increase from 2021.
- Relay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $48.5M, a 51.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)